Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Toric Contact Lens Digital Performance and Comfort Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04772560
Recruitment Status : Completed
First Posted : February 26, 2021
Results First Posted : March 10, 2022
Last Update Posted : March 10, 2022
Sponsor:
Information provided by (Responsible Party):
Kathryn Richdale, University of Houston

Brief Summary:
This study seeks to quantify digital visual performance and subjective visual acceptance of toric contact lenses as compared to spherical lenses in low to moderate astigmatic patients.

Condition or disease Intervention/treatment Phase
Astigmatism Device: Precision1 for Astigmatism Device: Precision1 Sphere Not Applicable

Detailed Description:
This study seeks to quantify the near visual performance and subjective visual acceptance of toric contact lenses as compared to spherical lenses in an astigmatic cohort of patients. Primary Hypotheses: Subjects will have better near visual acuity and near visual performance with toric, as opposed to spherical, contact lens correction. As such, the following hypotheses will be tested: H01: There is no statistically significant difference in near visual acuity or near vision performance between contact lenses corrections Ha1: There is a statistically significant difference in visual acuity or vision performance between contact lenses corrections

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Toric Contact Lens Digital Performance and Comfort Study
Actual Study Start Date : March 16, 2021
Actual Primary Completion Date : December 13, 2021
Actual Study Completion Date : December 13, 2021

Arm Intervention/treatment
Experimental: Toric, Then Sphere
Participants who received Toric contact lenses first and spherical lenses after 10 days
Device: Precision1 for Astigmatism
Daily disposable soft toric contact lens

Device: Precision1 Sphere
Daily disposable soft spherical contact lens

Experimental: Sphere, Then Toric
Participants who received Spherical contact lenses first and Toric lenses after 10 days
Device: Precision1 for Astigmatism
Daily disposable soft toric contact lens

Device: Precision1 Sphere
Daily disposable soft spherical contact lens




Primary Outcome Measures :
  1. Near Visual LogMAR Acuity [ Time Frame: 10 +/- 2 days ]
    High contrast LogMAR visual acuity was assessed at 40 cm using the M&S Clinical Trial Suite system (Niles, Illinois, USA). The system was calibrated according to the manufacturer's directions every day, prior to use. Testing was performed binocularly 10+/-2 days after each intervention. The test started at 20/60 and continued until three letters were missed on a line.

  2. Dynamic Visual Acuity [ Time Frame: 10 +/- 2 days ]
    Dynamic VA was determined using a custom-made iPad application. The subject was instructed to hold the iPad at 40cm and presented with a Landolt C surrounded by crowding bars for 0.3s each, starting from 0.5 LogMAR and progressing to smaller sizes using a staircase threshold method. Testing was performed binocularly 10+/-2 days after each intervention



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 39 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 to 39 years of age (inclusive)
  • pl to -6.00D vertexed sphere power and -0.75 to -1.50D vertexed refractive cylinder OD and OS
  • Current/established full time (>6 days week, >8 hours/day) soft contact lens wearer
  • Best corrected acuity of 20/25 or better in each eye
  • Self-report of at least 4 hrs/day using digital devices
  • Willing to wear lenses at least 8 hours each day during the study period
  • Able to speak and read English at a high school level / have at least a high school diploma or equivalent (by self-report)

Enclusion Criteria:

  • History of ocular pathology or surgery
  • Binocular vision disorder (i.e., tropia, convergence or accommodative insufficiency)
  • Gas permeable lens wear for at least 3 months
  • Symptomatic soft contact lens wearer (CLDEQ-8 score <12 at baseline)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04772560


Locations
Layout table for location information
United States, Texas
University of Houston College of Optometry
Houston, Texas, United States, 77204
Sponsors and Collaborators
Kathryn Richdale
Investigators
Layout table for investigator information
Principal Investigator: Kathryn Richdale University of Houston College of Optometry
  Study Documents (Full-Text)

Documents provided by Kathryn Richdale, University of Houston:
Statistical Analysis Plan  [PDF] December 20, 2021

Layout table for additonal information
Responsible Party: Kathryn Richdale, Associate professor, University of Houston
ClinicalTrials.gov Identifier: NCT04772560    
Other Study ID Numbers: STUDY00002753
First Posted: February 26, 2021    Key Record Dates
Results First Posted: March 10, 2022
Last Update Posted: March 10, 2022
Last Verified: February 2022

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Product Manufactured in and Exported from the U.S.: Yes
Additional relevant MeSH terms:
Layout table for MeSH terms
Astigmatism
Refractive Errors
Eye Diseases